Immune Reports Total Shares Outstanding
30. August 2013 17:00 ET
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y., Aug. 30, 2013 /PRNewswire/ -- Pursuant to the requirements of the Swedish Financial Supervisory Authority, Immune Pharmaceuticals Inc. (Nasdaq OMX Stockholm Exchange: IMNP and...
Immune Pharmaceuticals Restructures Secured Loan Following Completion of Merger
27. August 2013 00:52 ET
|
Immune Pharmaceuticals Inc
New Three-Year Term Enables Focus on Product Development
TARRYTOWN, N.Y., Aug. 27, 2013 /PRNewswire/ -- Immune Pharmaceuticals Inc. (Nasdaq OMX Stockholm Exchange: IMNP and OTCQX:...
Immune Pharmaceuticals Completes Merger with EpiCept Corporation
26. August 2013 01:33 ET
|
Immune Pharmaceuticals Inc
Common Stock Trading on Nasdaq OMX Stockholm Exchange and OTCQX Trading Platform
TARRYTOWN, New York, Aug. 26, 2013 /PRNewswire/ -- Immune Pharmaceuticals Inc. (Nasdaq OMX Stockholm Exchange:...
EpiCept Announces Reverse Stock Split and Change of Corporate Name to Immune Pharmaceuticals Inc.
20. August 2013 01:15 ET
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Aug. 20, 2013 /PRNewswire/ -- EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) (the "Company") and Immune Pharmaceuticals Ltd....
EpiCept Stockholders Overwhelmingly Approve Final Conditions to Merger with Immune Pharmaceuticals Ltd.
07. August 2013 17:00 ET
|
Immune Pharmaceuticals Inc
Almost 92% of Votes Cast in Favor of Proposals
Merger Expected to close in August 2013
TARRYTOWN, N.Y., Aug. 7, 2013 /PRNewswire/ -- EpiCept Corporation (Nasdaq and Nasdaq...
EpiCept Reports Second Quarter 2013 Operating and Financial Results
01. August 2013 00:10 ET
|
Immune Pharmaceuticals Inc
Special August 6 Stockholder Meeting to Approve Final Conditions to Merger with Immune Pharmaceuticals
TARRYTOWN, N.Y., Aug. 1, 2013 /PRNewswire/ -- EpiCept Corporation (Nasdaq OMX Stockholm...
EpiCept Issues Notice of Special Meeting of Stockholders on August 6 to Approve Important Aspects of the Proposed Merger with Immune Pharmaceuticals
20. Juni 2013 00:56 ET
|
Immune Pharmaceuticals Inc
Positive Vote Required to Enable Merger Closing
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm and OTCQX: EPCT) today issued notice
that stockholders of EpiCept are invited to the Special...
EpiCept Announces New Crolibulin Data Presented at ASCO 2013 Support Further Evaluation in Anaplastic Thyroid Cancer
03. Juni 2013 00:01 ET
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that
new data supporting further...
CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013
22. Mai 2013 00:01 ET
|
Immune Pharmaceuticals Inc
UPDATE ON BERTILIMUMAB DEVELOPMENT AND EPICEPT MERGER PROCESS
HERZLIYA-PITUACH, Israel & TARRYTOWN, N.Y.--(BUSINESS
WIRE (http://www.businesswire.com/))-- Regulatory News:
Immune Pharmaceuticals Ltd....
EpiCept Reports First Quarter 2013 Operating and Financial Results
20. Mai 2013 00:33 ET
|
Immune Pharmaceuticals Inc
PRELIMINARY PROXY STATEMENT FOR MERGER FILED WITH SEC
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX:...